A similar effect of incretins was demonstrated by Terasaki et al. [68] who attempted to study the association between the DPP-4 inhibitor and atherosclerosis in a murine model, but animals were administrated with DPP-4 inhibitor orally. Here, DPP4 is linked to atherosclerosis.